Young blood transfusions will end the disease in the elderly



[ad_1]

It seems that the famous Dracula was actually involved in something when he drank the blood of young girls.

While many companies have tinkered with blood transfusions of younger adults to treat age-related diseases, a leading geneticist from University College London is now in agreement to say that these experiences are not a joke being one of the most promising companies of modern medicine.

Publishing a data analysis in the journal Nature, Lady Linda Partridge, a geneticist, says research shows that young bloods could allow humans to live without diseases such as cancer, dementia, and heart disease until they are free. death.

His work is part of a wave of studies and trials, including a series of human trials supported by Peter Thiel in a San Francisco start-up called Ambrosia, which injects young blood to older adults. the public.

Professor Partridge's study showed that when older mice were given young blood, they did not develop age-related diseases and maintained a clear cognitive function, while the younger ones received the opposite effect. .

According to her, there is evidence that blood needs to be studied more closely in animals to identify molecules that maintain physical health.

Professor Partridge and co-authors Joris Deelen and P. Eline Slagboom add that blood is the most accessible and therefore most commonly studied tissue, but is much less used in animal studies.

The Ambrosia trials involved 70 participants receiving plasma, the main component of blood, from volunteers aged 16 to 25 years.

The researchers noted improvements in biomarkers of various major diseases, also known indicators for certain conditions.

This included a 10% reduction in blood cholesterol, which high levels are known to cause heart disease.

Scientists have also found a 20% reduction in proteins called carcinoembryonic antigens.

These can be seen in large numbers in people with various forms of cancer, says the website, but it remains to be seen if.

The younger blood has also helped halve amyloid protein levels, which form toxic clumps in the brains of patients with dementia.

However, the experts at The Ottawa Hospital made very different findings last July. They noted that blood donation among young women may be related to lower survival rates among recipients.

End of

[ad_2]
Source link